Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Predicted deadline: The deadline for this grant has passed

Grant amount: Unspecified amount

Funding uses: Research

Location of project: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Overview:

NOTE:  All types of non-AIDS applications allowed for this funding opportunity announcement are due by 5:00 PM local time of applicant organization on these dates:

• February 22, 2023
• June 22, 2023 

All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due y 5:00 PM local time of applicant organization on these dates: 

• May 7, 2023
• September 7,  2023

The purpose of this Program Announcement (PAR) is to enable analytical validation of strong candidate biomarkers for neurological diseases and conditions. Specifically, the goal of this PAR is to enable the rigorous validation of analytical methods for biomarker measurements, including evaluation of the detection method, its performance characteristics, and the optimal conditions that will generate reproducibility and accuracy consistent with FDA guidelines. This PAR assumes that:

• a candidate biomarker has already been identified,
• detection method technology has already been developed, and
• the research and/or clinical need and potential context of use has been identified.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.